From ‘Not Considering’ to ‘Inevitable Path’: Ai Er Ophthalmology Files for Hong Kong IPO
May 29, 2026 — 13:55 CST
This Data Is Locked!
This area is available only to Subscribers.
Ai Er Ophthalmology, the leading domestic private ophthalmology enterprise in China, has officially disclosed its prospectus for a Hong Kong IPO after experiencing a decline... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
